Researchers are investigating several types of cells and cell-derived products for their potential role in neurological repair. Each has different biological properties, and the appropriate approach depends on the disease, the affected tissue, and the stage of the condition.
🧬 1. Mesenchymal Stromal Cells (MSCs)
MSCs are among the most extensively studied cell types in regenerative medicine.
Rather than simply replacing damaged neurons, MSCs are primarily investigated for their paracrine and immunomodulatory effects, including the release of signaling molecules and extracellular vesicles that may influence inflammation, tissue repair, and cellular survival.
Potential research areas include:
Stroke
Spinal cord injury
Multiple sclerosis
Neuroinflammatory conditions
Peripheral nerve injuries
🧠 2. Neural Stem/Progenitor Cells (NSCs/NPCs)
Neural stem and progenitor cells can differentiate into neural-lineage cells, including neurons and glial cells.
Researchers are investigating whether these cells could contribute to neural repair, remyelination, and restoration of damaged neural pathways.
Potential applications include spinal cord injuries and selected neurodegenerative disorders.
🧬 3. iPSC-Derived Neural Progenitor Cells
Induced pluripotent stem cells (iPSCs) can be reprogrammed from mature cells and subsequently differentiated into neural progenitor cells.
This provides researchers with a potential source of specialized neural cells for studying:
Parkinson’s disease
Spinal cord injury
Neurodegenerative diseases
Neural tissue repair
iPSC-derived products are an important area of modern regenerative medicine research, although many therapeutic applications remain investigational.
🩸 4. Endothelial Progenitor Cells (EPCs)
EPCs are being studied for their potential role in angiogenesis and vascular repair.
Because adequate blood supply is essential for neural tissue survival, researchers are investigating whether improving vascularization and microcirculation could support recovery after neurological injury.
🧪 5. Exosomes & Extracellular Vesicles (EVs)
Exosomes and other extracellular vesicles are cell-derived signaling particles rather than stem cells themselves.
They can carry proteins, lipids, and regulatory RNA molecules between cells. Research is investigating their potential to influence:
Neuroinflammation
Oxidative stress
Angiogenesis
Neuronal survival
Tissue repair
Their potential advantage is that they may deliver biological signals without introducing living cells.
🔬 6. Other Specialized Cell Types
Depending on the research protocol, other cell populations are also being investigated, including:
Oligodendrocyte progenitor cells
Schwann cells
Astrocyte-related cellular approaches
Microvascular endothelial cells
iPSC-derived specialized neural cells
These approaches are generally more specialized and remain areas of active research.
Important to understand
There is no single “best” stem cell for neurological diseases. Different cell types have different mechanisms of action, and the scientific evidence varies considerably between conditions.
At Regenova BioTech, treatment suitability should be determined through an individualized medical assessment rather than selecting a cell type solely based on the diagnosis.How these cell types compare
MSCs: act mainly through signalling and immune modulation; the most widely studied in clinical trials; usually obtained from bone marrow, fat tissue or umbilical cord.
Neural stem/progenitor cells: can form new neural cells; studied mainly in spinal cord injury and selected neurodegenerative diseases; mostly early-phase research.
iPSC-derived neural cells: can be produced in large numbers and matched to specific cell types (for example dopamine-producing neurons for Parkinson's disease); early clinical trials are under way.
Endothelial progenitor cells: focus on blood vessel repair and circulation; mostly studied in stroke and vascular injury.
Exosomes and extracellular vesicles: cell-free signalling particles; an emerging research field with limited clinical data so far.
How are cells given in neurological studies?
The delivery route depends on the condition and the cell type. In clinical research, cells have been given intravenously, intrathecally (into the fluid around the spinal cord), by direct surgical implantation into the brain or spinal cord, and in some studies intranasally. Each route has different risks, and the safest and most appropriate route should be decided by the treating medical team.
What does the evidence show today?
Most studies in neurological diseases are still early-phase (phase I or II) trials. They mainly assess safety and feasibility, often in small groups of patients. Some trials, for example with MSCs after stroke or in multiple sclerosis, have reported encouraging signals, while others found no clear benefit. Larger controlled studies are needed before most of these approaches can become standard treatments. In Europe, cell-based therapies are regulated as Advanced Therapy Medicinal Products (ATMPs).
Questions to ask before considering treatment
Which cell type is proposed, and why is it suitable for my diagnosis?
Where are the cells produced, and how is their quality tested?
How will the cells be given, and what are the specific risks?
What published evidence exists for my condition?
How will results be measured and followed up?
Frequently asked questions
Which stem cells are used most for neurological diseases?
Mesenchymal stromal cells (MSCs) are the most widely studied in clinical research, mainly for their anti-inflammatory and supportive effects.
Can stem cells replace lost neurons?
Replacing neurons is the goal of neural progenitor and iPSC-derived cell research, but this remains experimental. Most current approaches aim to protect and support existing nerve tissue.
Are exosomes stem cells?
No. Exosomes are tiny particles released by cells. They carry biological signals but contain no living cells.
If you would like an individual assessment of your medical records, book a free consultation or contact us on WhatsApp at +49 176 5689 1000. This article is for general information and does not replace individual medical advice.
